The use of migraine preventative drugs on current clinical practice. An analysis based on a series of 400 patients
Abstract
Data di Pubblicazione:
2012
Citazione:
The use of migraine preventative drugs on current clinical practice. An analysis based on a series of 400 patients / M., B., M., M., Pini, L.A., C., L., C., D., F., M., G., Z.. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S54-S54. (XXVI National Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond Modena 26-28 October 2012).
Abstract:
In 2002 the Italian Society for the Study of Headaches (SISC)
introduced a second version of guidelines (GL) aimed to determine the most appropriate choice of drugs for the therapy of migraine. The impact of preventative GL in the general practice had been assessed in 1999, when drug use was evaluated respectively before (1989-92, n 351) and after (1995-98, n 204) the introduction of 1993 GL. Our aim was to establish the impact in migraine patients using the 2002 SISC GL.
The common use of migraine preventative drugs in current clinical practice differs in many aspects from the 2002 SISC GL. Very relevant is the fact that the number of patients who, despite
having the indication for preventative treatment are not receiving it, is very high (58.3%) and remains substantially unchanged during the years. A more adequate diffusion of the just published 2011 GL should be planned in order to effectively impact current practice. Furthermore, the promotion of the use of a headache diary could improve the therapeutic choice when a preventative
strategy is being considered.
introduced a second version of guidelines (GL) aimed to determine the most appropriate choice of drugs for the therapy of migraine. The impact of preventative GL in the general practice had been assessed in 1999, when drug use was evaluated respectively before (1989-92, n 351) and after (1995-98, n 204) the introduction of 1993 GL. Our aim was to establish the impact in migraine patients using the 2002 SISC GL.
The common use of migraine preventative drugs in current clinical practice differs in many aspects from the 2002 SISC GL. Very relevant is the fact that the number of patients who, despite
having the indication for preventative treatment are not receiving it, is very high (58.3%) and remains substantially unchanged during the years. A more adequate diffusion of the just published 2011 GL should be planned in order to effectively impact current practice. Furthermore, the promotion of the use of a headache diary could improve the therapeutic choice when a preventative
strategy is being considered.
Tipologia CRIS:
Abstract in Rivista
Keywords:
Migraine; preventative drugs
Elenco autori:
M., Bellamio; M., Margoni; Pini, Luigi Alberto; C., Lisotto; C., Disco; F., Maggioni; G., Zanchin
Link alla scheda completa:
Titolo del libro:
Supplement
Pubblicato in: